与危及生命的疾病相关的抑郁和焦虑的psilocybin辅助心理治疗:一个2b期随机对照试验
Margaret L Ross1, Ravi Iyer2, Martin L Williams3
1Department of Psychosocial Cancer Care, St. Vincent's Hospital Melbourne, Fitzroy, VIC, Australia; Palliative Medicine Unit, St. Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.
General hospital psychiatry
|August 26, 2025
概括
在患有危及生命的患者中,psilocybin辅助心理治疗显著降低了抑郁和焦虑. 这种新的治疗方法显示出持久的益处和改善生活质量,
科学领域:
- 精神病学和心理治疗
- 迷幻的研究
- 缓和护理
背景情况:
- 目前治疗危及生命的抑郁症和焦虑症的疗效有限.
- 这些疾病的治疗方法可能是新的.
研究的目的:
- 评估与安慰剂和心理治疗相比,松素辅助心理治疗的有效性和安全性.
- 评估被诊断患有危及生命的疾病和经历严重抑郁和/或焦虑的成年人的结果.
主要方法:
- 进行了一项双盲,随机控制的2b期试验,并进行了开放式扩展.
- 参与者在心理治疗期间接受了25毫克psilocybin或 niacin (活性安慰剂).
- 使用医院焦虑和抑郁量表 (HADS),贝克抑郁量表-II (BDI-II) 和国家焦虑量表 (STAI-S) 来评估症状变化.
主要成果:
- 与安慰剂相比,在6至7周内,思洛西宾治疗显著减少了抑郁和焦虑症状.
- 这些益处在治疗后26周保持.
- 调查结果显示,人们的精神健康有所提升,生活质量有所改善,死亡的焦虑和绝望感有所减少. 观察到轻度至中度的不良事件,没有严重的治疗事件.
结论:
- 在患有危及生命疾病的患者中,psilocybin辅助心理治疗证明了减轻抑郁和焦虑症状的安全性和有效性.
- 这种治疗提供了持久的缓解和心理健康的潜在改善,
- 这种方法可能为息治疗提供一种有价值的新选择.
更多相关视频
相关概念视频
Interpersonal Psychotherapy
99
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
99
Psychosurgery
104
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
104
Behavior Therapy
106
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
106
Electroconvulsive Therapy
185
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
185
Psychotherapy
171
Psychotherapy is a versatile, nonmedical approach aimed at helping individuals address emotional, behavioral, and interpersonal issues to enhance their overall well-being. It can involve one-on-one sessions, couples counseling, or small group discussions with a therapist. The therapeutic process includes various techniques such as open discussion, interpretation of thoughts and behaviors, active listening, positive reinforcement, and role modeling. Psychotherapy aims to support individuals in...
171
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209


